N-[5-(AMINOSULFONYL)-4-METHLY-1,3-THIAZOL-2-YL]-N-METHYL-2-[4-(2-[PYRIDINYL)PHENYL]ACETAMIDE MESYLATE MONOHYDRATE

N-[5-(AMINOSULFONYL)-4-METHLY-1,3-THIAZOL-2-YL]-N-METHYL-2-[4-(2-[PYRIDINYL)PHENYL]ACETAMIDE MESYLATE MONOHYDRATE

The present invention relates to an improved and shortened synthesis of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide and the mesylate monohydrate salt thereof by using boronic acid derivatives or borolane reagents while avoiding toxic organic tin compou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: VOGTLI, KURT, KEIL, BIRGIT, REHSE, JAOCHIM, GRUNENBERG, ALFONS, BIRKMANN, ALEXANDER, LENDER, ANDREAS, SCHWAB, WILFRIED, HAAG, DIETER
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to an improved and shortened synthesis of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide and the mesylate monohydrate salt thereof by using boronic acid derivatives or borolane reagents while avoiding toxic organic tin compounds and to the mesylate monohydrate salt of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acet-amide which has demonstrated increased long term stability and release kinetics from pharmaceutical compositions.